Central Nervous System Lesions in COVID-19

Overview

Journal Neurosci Behav Physiol

Publisher Springer

Date 2022 Jan 10

PMID 35001988

Authors

O V Kurushina

A E Barulin

Affiliations

Soon will be listed here.

Abstract

This review discusses current data on CNS lesions in infections with the new coronavirus that causes COVID-19. The pathogenetic mechanisms leading to infection of the brain and spinal cord are presented. Published studies and meta-analyses published by autumn 2020 are assessed. The authors present results from their own clinical observations of various types of CNS infection in COVID-19 virus disease. Particular attention is paid to certain common forms of CNS lesion such as encephalitis, cerebrovascular pathology, and headache. A form of acute hemorrhagic necrotic encephalopathy is identified, which is a quite rare but fatal pathology comorbid with COVID-19. A description of our own clinical observation of acute necrotic encephalopathy is presented. The importance of further studies of the effects of the coronavirus on the CNS and possible approaches to treatment and rehabilitation of this category of patients is emphasized.

Citing Articles

Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases.

Plantone D, Stufano A, Righi D, Locci S, Iavicoli I, Lovreglio P Sci Rep. 2024; 14(1):6429.

PMID: 38499607 PMC: 10948776. DOI: 10.1038/s41598-024-57093-z.

Symeonidou E, Dimitriadou A, Morsi-Yeroyannis A, Sidiropoulou M, Gkoutziotis I, Petras P Arch Clin Cases. 2023; 10(2):78-85.

PMID: 37293685 PMC: 10246599. DOI: 10.22551/2023.39.1002.10246.

References

Li Y, Bai W, Hashikawa T . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92(6):552-555. PMC: 7228394. DOI: 10.1002/jmv.25728. View

Tveito K . Cytokine storms in COVID-19 cases?. Tidsskr Nor Laegeforen. 2020; 140. DOI: 10.4045/tidsskr.20.0239. View

Rao H, Jayabaskaran C . The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol. 2020; 92(7):786-790. PMC: 7264535. DOI: 10.1002/jmv.25918. View

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B . COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020; 296(2):E119-E120. PMC: 7233386. DOI: 10.1148/radiol.2020201187. View

Filatov A, Sharma P, Hindi F, Espinosa P . Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus. 2020; 12(3):e7352. PMC: 7170017. DOI: 10.7759/cureus.7352. View

Benger M, Williams O, Siddiqui J, Sztriha L . Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series. Brain Behav Immun. 2020; 88:940-944. PMC: 7276127. DOI: 10.1016/j.bbi.2020.06.005. View

Correia A, Feitosa P, Moreira J, Nogueira S, Fonseca R, Nobre M . Neurological manifestations of COVID-19 and other coronaviruses: A systematic review. Neurol Psychiatry Brain Res. 2020; 37:27-32. PMC: 7261450. DOI: 10.1016/j.npbr.2020.05.008. View

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368:m1091. PMC: 7190011. DOI: 10.1136/bmj.m1091. View

Wang J, Hajizadeh N, Moore E, McIntyre R, Moore P, Veress L . Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. 2020; 18(7):1752-1755. PMC: 7262152. DOI: 10.1111/jth.14828. View

10.

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J . A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94:55-58. PMC: 7195378. DOI: 10.1016/j.ijid.2020.03.062. View

11.

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z . Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18(5):1094-1099. PMC: 9906401. DOI: 10.1111/jth.14817. View

12.

Scullen T, Keen J, Mathkour M, Dumont A, Kahn L . Coronavirus 2019 (COVID-19)-Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience. World Neurosurg. 2020; 141:e437-e446. PMC: 7255727. DOI: 10.1016/j.wneu.2020.05.192. View

13.

Tu H, Tu S, Gao S, Shao A, Sheng J . Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect. 2020; 81(1):1-9. PMC: 7166041. DOI: 10.1016/j.jinf.2020.04.011. View

14.

Steardo L, Steardo Jr L, Zorec R, Verkhratsky A . Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf). 2020; 229(3):e13473. PMC: 7228251. DOI: 10.1111/apha.13473. View

15.

Ahmad I, Rathore F . Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020; 77:8-12. PMC: 7200361. DOI: 10.1016/j.jocn.2020.05.017. View

16.

Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R, Kramer S . Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020; 267(8):2196-2197. PMC: 7250275. DOI: 10.1007/s00415-020-09934-w. View

17.

Reddy S, Garg T, Shah C, Nascimento F, Imran R, Kan P . Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series. Case Rep Neurol. 2020; 12(2):199-209. PMC: 7325208. DOI: 10.1159/000508958. View

18.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

19.

Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dube M . Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?. Viruses. 2019; 12(1). PMC: 7020001. DOI: 10.3390/v12010014. View

20.

Rodriguez-Morales A, Cardona-Ospina J, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana J . Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020; 34:101623. PMC: 7102608. DOI: 10.1016/j.tmaid.2020.101623. View